224 related articles for article (PubMed ID: 37781522)
1. Hypoxia-induced exosomes facilitate lung pre-metastatic niche formation in hepatocellular carcinoma through the miR-4508-RFX1-IL17A-p38 MAPK-NF-κB pathway.
Jia W; Liang S; Lin W; Li S; Yuan J; Jin M; Nie S; Zhang Y; Zhai X; Zhou L; Ling C; Cheng B; Ling C
Int J Biol Sci; 2023; 19(15):4744-4762. PubMed ID: 37781522
[No Abstract] [Full Text] [Related]
2. Oleanolic acid inhibits hypoxic tumor-derived exosomes-induced premetastatic niche formation in hepatocellular carcinoma by targeting ERK1/2-NFκB signaling.
Jia W; Liang S; Jin M; Li S; Yuan J; Zhang J; Lin W; Wang Y; Nie S; Ling C; Cheng B
Phytomedicine; 2024 Apr; 126():155208. PubMed ID: 38387275
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Fang T; Lv H; Lv G; Li T; Wang C; Han Q; Yu L; Su B; Guo L; Huang S; Cao D; Tang L; Tang S; Wu M; Yang W; Wang H
Nat Commun; 2018 Jan; 9(1):191. PubMed ID: 29335551
[TBL] [Abstract][Full Text] [Related]
4. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K
Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced exosomes promote hepatocellular carcinoma proliferation and metastasis via miR-1273f transfer.
Yu Y; Min Z; Zhou Zhihang ; Linhong M; Tao R; Yan L; Song H
Exp Cell Res; 2019 Dec; 385(1):111649. PubMed ID: 31562861
[TBL] [Abstract][Full Text] [Related]
6. Exosome-mediated transfer of circRNA563 promoting hepatocellular carcinoma by targeting the microRNA148a-3p/metal-regulatory transcription factor-1 pathway.
Lyu ZZ; Li M; Yang MY; Han MH; Yang Z
World J Gastroenterol; 2023 Dec; 29(46):6060-6075. PubMed ID: 38130740
[TBL] [Abstract][Full Text] [Related]
7. Hsa-microRNA-27b-3p inhibits hepatocellular carcinoma progression by inactivating transforming growth factor-activated kinase-binding protein 3/nuclear factor kappa B signalling.
Wen J; Huang Z; Wei Y; Xue L; Wang Y; Liao J; Liang J; Chen X; Chu L; Zhang B
Cell Mol Biol Lett; 2022 Sep; 27(1):79. PubMed ID: 36138344
[TBL] [Abstract][Full Text] [Related]
8. Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells.
Matsuura Y; Wada H; Eguchi H; Gotoh K; Kobayashi S; Kinoshita M; Kubo M; Hayashi K; Iwagami Y; Yamada D; Asaoka T; Noda T; Kawamoto K; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
Dig Dis Sci; 2019 Mar; 64(3):792-802. PubMed ID: 30465177
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia derived exosomes promote the proliferation and metastasis of colorectal cancer through the regulation of HIF-1α/miR-4299/ZBTB4.
Wu L; Xue M; Lai S; Chen J; Lin Y; Ding N; Zhong J; Chen S; Wang L
Life Sci; 2023 Sep; 329():121872. PubMed ID: 37352917
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.
Zhao N; Wang R; Zhou L; Zhu Y; Gong J; Zhuang SM
Mol Cancer; 2014 Feb; 13():35. PubMed ID: 24565101
[TBL] [Abstract][Full Text] [Related]
11. LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway.
Li Y; Zhao J; Zhang W; Wang A; Jiao M; Cai X; Zhu J; Liu Z; Huang JA
Cell Cycle; 2022 Dec; 21(23):2455-2470. PubMed ID: 35852407
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p.
Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551
[TBL] [Abstract][Full Text] [Related]
13. miR-3928v is induced by HBx via NF-κB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3.
Zhang Q; Song G; Yao L; Liu Y; Liu M; Li S; Tang H
J Exp Clin Cancer Res; 2018 Jan; 37(1):14. PubMed ID: 29378599
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic lung cancer cell-derived exosomal miR-21 mediates macrophage M2 polarization and promotes cancer cell proliferation through targeting IRF1.
Jin J; Yu G
World J Surg Oncol; 2022 Jul; 20(1):241. PubMed ID: 35897096
[TBL] [Abstract][Full Text] [Related]
15. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y
Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827
[TBL] [Abstract][Full Text] [Related]
16. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
[TBL] [Abstract][Full Text] [Related]
17. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
[TBL] [Abstract][Full Text] [Related]
18. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
[No Abstract] [Full Text] [Related]
19. Hypoxic tumor-derived exosomal miR-31-5p promotes lung adenocarcinoma metastasis by negatively regulating SATB2-reversed EMT and activating MEK/ERK signaling.
Yu F; Liang M; Huang Y; Wu W; Zheng B; Chen C
J Exp Clin Cancer Res; 2021 Jun; 40(1):179. PubMed ID: 34074322
[TBL] [Abstract][Full Text] [Related]
20. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.
Fu X; Liu M; Qu S; Ma J; Zhang Y; Shi T; Wen H; Yang Y; Wang S; Wang J; Nan K; Yao Y; Tian T
J Exp Clin Cancer Res; 2018 Mar; 37(1):52. PubMed ID: 29530052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
